title: CD8αα Expression Marks Terminally Differentiated Human CD8+ T Cells Expanded in Chronic Viral Infection.
abstract: The T cell co-receptor CD8αβ enhances T cell sensitivity to antigen, however studies indicate CD8αα has the converse effect and acts as a co-repressor. Using a combination of Thymic Leukemia (TL) antigen tetramer, which directly binds CD8αα, anti-CD161, and anti-Vα7.2 antibodies we have been able for the first time to clearly define CD8αα expression on human CD8 T cells subsets. In healthy controls CD8αα is most highly expressed by CD161 "bright" (CD161++) mucosal associated invariant T (MAIT) cells, with CD8αα expression highly restricted to the TCR Vα7.2+ cells of this subset. We also identified CD8αα-expressing populations within the CD161 "mid" (CD161+) and "negative" (CD161-) non-MAIT CD8 T cell subsets and show TL-tetramer binding to correlate with expression of CD8β at low levels in the context of maintained CD8α expression (CD8α+CD8β(low)). In addition, we found CD161-CD8α+CD8β(low) populations to be significantly expanded in the peripheral blood of HIV-1 and hepatitis B (mean of 47 and 40% of CD161- T cells respectively) infected individuals. Such CD8αα expressing T cells are an effector-memory population (CD45RA-, CCR7-, CD62L-) that express markers of activation and maturation (HLA-DR+, CD28-, CD27-, CD57+) and are functionally distinct, expressing greater levels of TNF-α and IFN-γ on stimulation and perforin at rest than their CD8α+CD8β(high) counterparts. Antigen-specific T cells in HLA-B(∗)4201+HIV-1 infected patients are found within both the CD161-CD8α+CD8β(high) and CD161-CD8α+CD8β(low) populations. Overall we have clearly defined CD8αα expressing human T cell subsets using the TL-tetramer, and have demonstrated CD161-CD8α+CD8β(low) populations, highly expanded in disease settings, to co-express CD8αβ and CD8αα. Co-expression of CD8αα on CD8αβ T cells may impact on their overall function in vivo and contribute to the distinctive phenotype of highly differentiated populations in HBV and HIV-1 infection.
authors: Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford , Oxford , UK ; Institute of Cellular Medicine, Newcastle University , Newcastle upon Tyne , UK.
authors: L J
authors: LJ
authors: Walker
authors: E
authors: E
authors: Marrinan
authors: M
authors: M
authors: Muenchhoff
authors: J
authors: J
authors: Ferguson
authors: H
authors: H
authors: Kloverpris
authors: H
authors: H
authors: Cheroutre
authors: E
authors: E
authors: Barnes
authors: P
authors: P
authors: Goulder
authors: Paul
authors: P
authors: Klenerman
keywords: CD8+ T cells; CD8α; HIV-1; hepatitis B; hepatitis C
references: Eur J Immunol. 1991 Aug;21(8):1793-800
references: 1831127
references: Immunity. 2003 Feb;18(2):255-64
references: 12594952
references: J Immunol. 2003 Nov 1;171(9):4493-503
references: 14568922
references: Cell Immunol. 2000 Apr 10;201(1):58-62
references: 10805974
references: Tissue Antigens. 2007 Sep;70(3):179-89
references: 17661905
references: Blood. 2011 Aug 25;118(8):2138-49
references: 21734237
references: J Am Geriatr Soc. 2010 Aug;58(8):1565-75
references: 20942872
references: Eur J Immunol. 2007 Jun;37(6):1634-41
references: 17506031
references: Cell. 1988 Oct 21;55(2):301-8
references: 3262426
references: Exp Gerontol. 2007 May;42(5):432-7
references: 17307327
references: J Virol. 2000 Jul;74(13):5769-75
references: 10846055
references: Science. 2001 Nov 30;294(5548):1936-9
references: 11729321
references: J Immunol. 2002 Nov 15;169(10):5708-14
references: 12421950
references: Science. 2004 Apr 23;304(5670):590-3
references: 15105501
references: Clin Exp Immunol. 2010 Mar;159(3):245-55
references: 19968665
references: J Exp Med. 2008 Sep 1;205(9):2111-24
references: 18695005
references: Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7
references: 8633023
references: J Immunol. 1992 Sep 1;149(5):1613-8
references: 1506684
references: Vaccine. 2006 Feb 20;24(8):1159-69
references: 16213065
references: J Immunol. 2005 Mar 15;174(6):3501-7
references: 15749886
references: Immunology. 2009 Feb;126(2):147-64
references: 19125886
references: Blood. 1998 Jul 1;92(1):198-206
references: 9639517
references: Blood. 2002 Dec 1;100(12):4090-7
references: 12393564
references: J Immunol. 2002 Oct 1;169(7):3492-8
references: 12244138
references: Scand J Immunol. 2008 May;67(5):501-8
references: 18405327
references: Blood. 1997 Nov 1;90(9):3662-72
references: 9345051
references: J Immunol. 2002 Apr 15;168(8):3881-6
references: 11937542
references: J Biol Chem. 2007 Aug 17;282(33):23799-810
references: 17540778
references: J Immunol. 2008 Jun 1;180(11):7276-86
references: 18490727
references: J Immunol. 2009 Jul 15;183(2):1044-54
references: 19553528
references: Aging Dis. 2011 Oct;2(5):382-397
references: 22308228
references: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3006-11
references: 20133607
references: Clin Immunol Immunopathol. 1996 Nov;81(2):129-35
references: 8906743
references: Clin Exp Immunol. 2003 Sep;133(3):334-43
references: 12930358
references: Immunity. 2006 Oct;25(4):631-41
references: 17045820
references: J Biol Chem. 2005 Jul 29;280(30):27491-501
references: 15837791
references: Nat Med. 2002 Apr;8(4):379-85
references: 11927944
references: Nat Immunol. 2011 Oct 02;12(11):1086-95
references: 21964609
references: Immun Ageing. 2007 Dec 11;4:9
references: 18072962
references: Blood. 2012 Jan 12;119(2):422-33
references: 22086415
references: J Immunol. 2011 Feb 15;186(4):2672-80
references: 21248258
references: J Exp Med. 1996 Dec 1;184(6):2439-44
references: 8976201
references: Semin Immunol. 2012 Oct;24(5):373-82
references: 22633440
references: Immunity. 2003 Feb;18(2):205-15
references: 12594948
references: Immunity. 2008 Feb;28(2):149-59
references: 18275828
references: PLoS Biol. 2004 Feb;2(2):E20
references: 14966528